Skip to content
Specimen Atlas of Research Peptides81 plates · MIT
Side-by-side · Research reference

DSIPvsSNAP-8

Side-by-side comparison across mechanism, dosage, evidence, side effects, administration, and stack synergies. Citations on every claim where available.

AHuman-MechanisticAUTO-DRAFTED8/36 cited
BHuman-MechanisticHUMAN-REVIEWED8/46 cited
DSIP
Sleep modulator · Anti-stress
100–200 mcgPer doseSchneider 1986
HumanMechanisticSchneider 1986
HoursHalf-life (est)
SQ · Pre-sleep · Daily during cycle
SNAP-8
Synthetic Octapeptide · Cosmetic Topical
TopicalRoute
8-AAPeptide length
SNAREPrimary target
Topical · Facial application · Twice daily

01Mechanism of Action

Parameter
DSIP
SNAP-8
Primary target
Multiple — modulates HPA axis + thalamic delta-wave generation (proposed)Schneider 1986
SNARE complex (SNAP-25 competitive binding site)
Pathway
Reduced cortisol/ACTH + enhanced delta-wave EEG activity → improved sleep onset + depthSchneider 1986
Acetyl octapeptide-3 → SNARE complex disruption → Reduced vesicular fusion → Decreased acetylcholine release → Muscle relaxation
Downstream effect
Faster sleep onset, increased delta sleep, reduced stress response, possible anxiolytic effectSchneider 1986
Transient reduction in neuromuscular signal transmission, decreased muscle contraction amplitude, wrinkle depth reduction
Feedback intact?
N/A — topical cosmetic, no systemic endocrine axis
Origin
Endogenous peptide first isolated from rabbit blood during delta sleep; synthesised exogenouslySchneider 1986
Synthetic peptide derived from N-terminal fragment of SNAP-25 protein (synaptosomal-associated protein 25 kDa)
Antibody development

02Dosage Protocols

Parameter
DSIP
SNAP-8
Standard dose
100–200 mcg SQ pre-sleepSchneider 1986
Frequency
Once daily, pre-sleep
Lower / starter dose
50 mcg pre-sleep
Evidence basis
Human-mechanistic + early clinicalSchneider 1986
RCT, in vitro skin penetration studies
Duration
8–12 weeks per cycle
Reconstitution
Bacteriostatic water
Timing
30–60 min pre-sleep
Half-life
Short plasma; CNS effects last hours
Typical concentration
2–10% in cosmetic formulationsLupin 2024Raikou 2017
Commercial products typically use 5–10%.
Application frequency
Twice daily (morning and evening)Lupin 2024
Treatment duration
20–60 days for visible effectRaikou 2017
Skin microtopography improvements measured at 20-day intervals.
Formulation type
Oil-in-water emulsion, serum, cream
Application site
Facial skin — glabellar lines, crow's feet, forehead
Onset of effect
Visible reduction in wrinkle depth by day 20–28Raikou 2017

03Metabolic / Fat Loss Evidence

04Side Effects & Safety

Parameter
DSIP
SNAP-8
Injection site reaction
Mild irritation
Drowsiness
Expected effect (intentional)
Vivid dreams
Anecdotally reported
Long-term safety
Limited modern RCT data
Pregnancy / OB
Avoid
Cytotoxicity
Concentration-dependent antiproliferative effect observed in vitro; IC50 ~10 mg/mL (argireline, 6-AA analogue)
Commercial formulations typically use 0.05–0.1 mg/mL, well below cytotoxic threshold.
Skin irritation
Minimal; well-tolerated in clinical use
Peptide oxidation
Methionine residue susceptible to oxidation in formulation; may reduce efficacyKluczyk 2021
Formulation stability issue, not a direct adverse effect.
Systemic absorption
Negligible; peptide remains in stratum corneum and epidermisKraeling 2015
Hypersensitivity
Rare; no widespread allergic reactions reported
Absolute Contraindications
DSIP
  • ·Pregnancy / breastfeeding
  • ·Concurrent CNS-depressant therapy without supervision
SNAP-8
  • ·Known hypersensitivity to acetyl octapeptide-3 or formulation excipients
Relative Contraindications
DSIP
  • ·Severe sleep apnoea (untreated)
  • ·Concurrent benzodiazepine / opioid use
SNAP-8
  • ·Active skin infections or open wounds at application site
  • ·Neuromuscular disorders (theoretical concern, no documented cases)

05Administration Protocol

Parameter
DSIP
SNAP-8
1. Reconstitution
Add 1–2 mL bacteriostatic water to vial.
Wash face with gentle cleanser and pat dry. Remove makeup and surface oils to optimize peptide contact.
2. Injection site
SQ — abdomen. Rotate sites.
Apply 1–2 drops or pea-sized amount of SNAP-8 serum or cream to target areas (forehead, glabellar lines, crow's feet). Gently massage until absorbed.
3. Timing
30–60 min pre-sleep.
Twice daily — morning and evening. Allow 2–3 minutes for absorption before applying additional skincare products.
4. Storage
Lyophilised: room temp. Reconstituted: refrigerate ≤30 days.
Apply before heavier creams or occlusive moisturizers. Peptides penetrate best from water-based serums on clean skin.
5. Needle
29–31G insulin syringe.
Store at room temperature, away from direct sunlight. Refrigeration may extend shelf life of formulations containing unstable peptides.
6. Duration
Consistent use for 20–60 days required for visible wrinkle reduction. Effects are temporary and reverse upon discontinuation.